Griswold, CT, United States of America

V John Jasys



Average Co-Inventor Count = 3.4

ph-index = 1

Forward Citations = 4(Granted Patents)


Location History:

  • New London, CT (US) (1992)
  • Griswold, CT (US) (2005)

Company Filing History:


Years Active: 1992-2005

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations of V John Jasys

Introduction

V John Jasys is a notable inventor based in Griswold, Connecticut, who has made significant contributions to the field of chemistry. He holds two patents that showcase his innovative approach to developing new compounds with practical applications.

Latest Patents

His latest patents include "Dihydroxyhexanoic acid derivatives, their intermediates, and methods of making." This invention relates to dihydroxyhexanoic acid derivatives and their intermediates, as well as methods for preparing such compounds. Additionally, the invention addresses the removal of a protecting group from a protected amine by reacting the protected amine with phosphoric acid. Another significant patent is for "Beta-lactam elastase inhibitors." This patent discloses novel beta-lactam compounds that exhibit potent elastase inhibition activity. These compounds are characterized by specific structural formulae and are particularly useful as anti-inflammatory agents in treating conditions such as adult respiratory distress syndrome and rheumatoid arthritis.

Career Highlights

V John Jasys is currently associated with Pfizer Corporation, a leading pharmaceutical company known for its innovative research and development in healthcare. His work at Pfizer has allowed him to contribute to advancements in medicinal chemistry and drug development.

Collaborations

Throughout his career, he has collaborated with notable colleagues, including Robert A Volkmann and Michael S Kellogg, which has further enriched his research and innovation efforts.

Conclusion

V John Jasys exemplifies the spirit of innovation in the field of chemistry through his patents and contributions to pharmaceutical research. His work continues to impact the development of new therapeutic agents.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…